HRT Financial’s Agilon Health AGL Stock Holding History

HRT Financial’s Portfolio AGL Stock Details AGL Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$246K	Buy	+2,300	New	+$151K	﹤0.01%	3271

Other funds holding AGL

CDR

Clayton Dubilier & Rice New York $895M AUM 792.56% 1-Year Est. Return

Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return

NPCM

North Peak Capital Management New York $900M AUM 193.67% 1-Year Est. Return

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

AQR Capital Management Greenwich, Connecticut $287B AUM 42.33% 1-Year Est. Return

Goldman Sachs New York $1.15T AUM 47.82% 1-Year Est. Return

Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM

Marshall Wace London, United Kingdom $127B AUM 46.06% 1-Year Est. Return

DCP

Durable Capital Partners Bethesda, Maryland $10.3B AUM 29.04% 1-Year Est. Return

D.E. Shaw & Co New York $210B AUM 57.28% 1-Year Est. Return

HRT Financial's AGL Position: Q1 2026 in Review

HRT Financial sold out of Agilon Health (AGL) in Q1 2026, closing a stake of 22,607 shares — an estimated $389K sold.

HRT Financial first reported a position in AGL in Q1 2023 and held it in 4 quarters. The position peaked at $22.6M in Q1 2023. 97 funds tracked by Wall St. Rank hold AGL as of Q1 2026.

HRT Financial reported no remaining Agilon Health position as of Q1 2026 after selling out during the quarter.
HRT Financial sold 22,607 Agilon Health shares in Q1 2026, an estimated $389K.
HRT Financial first reported a position in Agilon Health in Q1 2023 and held it in 4 quarters.
HRT Financial's Agilon Health position peaked at $22.6M in Q1 2023.
97 funds tracked by Wall St. Rank held Agilon Health as of Q1 2026.

Based on HRT Financial's 13F filing for Q1 2026, filed 14 May 2026.